PHF2 and acute myeloid leukemia: In summary, ML models using phosphoproteomics data accurately classified AML primary samples as sensitive or resistant to ex vivo treatment with 1 μM of PF-3758309 and provided further evidence that phosphorylation of PHF2 at Ser705 predicts sensitivity to PF-3758309.